Escient Pharmaceuticals Revenue and Competitors
Estimated Revenue & Valuation
- Escient Pharmaceuticals's estimated annual revenue is currently $4.7M per year.
- Escient Pharmaceuticals's estimated revenue per employee is $77,500
- Escient Pharmaceuticals's total funding is $238M.
Employee Data
- Escient Pharmaceuticals has 60 Employees.
- Escient Pharmaceuticals grew their employee count by 15% last year.
Escient Pharmaceuticals's People
| Name | Title | Email/Phone |
|---|---|---|
1 | CEO | Reveal Email/Phone |
2 | SVP | Reveal Email/Phone |
3 | SVP and Head Clinical Development | Reveal Email/Phone |
4 | VP and Head Biology | Reveal Email/Phone |
5 | VP, DMPK and Toxicology | Reveal Email/Phone |
6 | VP, Finance and Administration | Reveal Email/Phone |
7 | VP CMC | Reveal Email/Phone |
8 | VP Regulatory Affairs | Reveal Email/Phone |
9 | Associate Director, Clinical Supplies | Reveal Email/Phone |
10 | Director, Chemistry | Reveal Email/Phone |
Escient Pharmaceuticals Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $4.4M | 57 | -8% | $53M | N/A |
#2 | $21.2M | 137 | -26% | $110M | N/A |
#3 | $0.9M | 6 | 0% | N/A | N/A |
#4 | $2.3M | 15 | 15% | N/A | N/A |
#5 | $1.6M | 10 | -17% | N/A | N/A |
#6 | $0.7M | 9 | 50% | N/A | N/A |
#7 | $11.5M | 74 | -12% | N/A | N/A |
#8 | $0.4M | 275 | 10% | $236.7M | N/A |
#9 | $4M | 51 | -74% | $160M | N/A |
#10 | $2.3M | 15 | 15% | N/A | N/A |
What Is Escient Pharmaceuticals?
We are a privately held biotechnology company that is advancing first-in-class G Protein-Coupled Receptor (GPCR)-targeted drugs to address serious, unserved medical needs across a broad range of therapeutic indications. We are focused on unleashing the therapeutic potential of specific orphan GPCRs, including the novel family of Mas-Related G-Protein Receptors (Mrgprs), and will initially pursue medicines for neuro-immuno-inflammatory and autoreactive diseases. Based in San Diego, we are led by an experienced team of entrepreneurs with deep roots in this regionￃﾢ￢ﾂﾬ￢ﾄﾢs life sciences ecosystem and specific expertise in GPCR drug discovery and development. Escient Pharmaceuticals is supported by top-tier life-sciences investors with a proven track record for identifying and supporting successful, next-generation medicines companies.
keywords:N/A
$238M
Total Funding
60
Number of Employees
$4.7M
Revenue (est)
15%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Escient Pharmaceuticals News
Photo Courtesy of Escient Pharmaceuticals. San Diego biotech Escient Pharmaceuticals reeled in $77.5 million in its latest funding round. San Diego-based biotech Escient Pharmaceuticals, has announced it has raised a $77... Take 1 minute to subscribe and you'll get this story immediately, plus ...
San Diego-based Escient Pharmaceuticals, which is developing treatments for mast cell-related diseases, said on Monday that it has raised $77.5M in a Series B funding round. According to the company, the funding round was led by Sanofi Ventures and Cowen Healthcare Investments and included new i ...
Escient Pharmaceutials, a San Diego, CA-based biotech company, closed $40m in Series A funding. Backers included The Column Group, 5AM Ventures and Osage University Partners. In conjunction with the funding, JJ Kang, Ph.D., Principal at The Column Group, Andrew J. Schwab, Founder and Managing P ...
Other Companies in San Diego
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $5.5M | 60 | 22% | N/A |
#2 | $17.8M | 60 | 0% | N/A |
#3 | $7.8M | 60 | N/A | N/A |
#4 | $11.3M | 60 | N/A | N/A |
#5 | $7.5M | 60 | N/A | N/A |